Horizon to use CRISPR tech to enhance CHO cell lines for biomanufacturing – BioPharma-Reporter.com
|
Horizon to use CRISPR tech to enhance CHO cell lines for biomanufacturing
BioPharma-Reporter.com Cambridge, UK-based gene editing company Horizon licensed its CRISPR technology from ERS Genomics in 2014 and yesterday announced it had extended the deal to include the rights to use the platform to edit cell lines for GMP biomanufacturing. |
